(Q40457651)

20 September 2017

1 reference

title

Gene-modified cells for the treatment of cancer (English)

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

23 June 2024

author name string

K. A. Whartenby

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630929

23 June 2024

G. N. Abraham

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630929

23 June 2024

P. A. Calabresi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630929

23 June 2024

C. N. Abboud

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630929

23 June 2024

P. Calabresi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630929

23 June 2024

A. Marrogi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630929

23 June 2024

S. M. Freeman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630929

23 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7630929

23 June 2024

publication date

1 April 1995

1 reference

full work available at URL

20 September 2017

https://doi.org/10.1016/0163-7258(94)00081-d

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7630929

https://api.elsevier.com/content/article/PII:016372589400081D?httpAccept=text/xml

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

https://api.elsevier.com/content/article/PII:016372589400081D?httpAccept=text/plain

23 June 2024

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Pharmacology & Therapeutics

23 June 2024

published in

1 reference

20 September 2017

volume

66

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

175-190

1 reference

A safe packaging line for gene transfer: separating viral genes on two different plasmids

20 September 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1128/JVI.62.4.1120-1124.1988

Adoptively Transferred Tumor-Infiltrating Lymphocytes Can Cure Established Metastatic Tumor in Mice and Persist Long-Term In Vivo as Functional Memory T Lymphocytes

1

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer

23 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Targeting of an inducible toxic phenotype in animal cells

23 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Prospects for gene-directed therapy with antisense oligodeoxynucleotides

23 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

23 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Regression of established macroscopic liver metastases after in situ transduction of a suicide gene

23 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors

23 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer

23 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

The chemotherapeutic exploitation of virus-specified enzymes

23 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene

23 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

A genetic model for colorectal tumorigenesis

23 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

23 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma

23 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Germ-line Gene Therapy: A New Stage of Debate

23 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Aniridia-Wilms’ tumor association: evidence for specific deletion of 11p13

23 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Gene therapy for human genetic disease?

23 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

23 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells

23 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Partial correction of murine hereditary growth disorder by germ-line incorporation of a new gene

23 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Tumor suppressor genes: new prospects for cancer research

23 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy

23 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Human gene therapy: present and future

23 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Gene transfer by electroporation: a model for gene therapy

23 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

The approaching era of the tumor suppressor genes

23 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer

23 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

A Potential Approach for Gene Therapy Targeting Hepatoma Using a Liver-Specific Promoter on a Retroviral Vector

23 June 2024

34

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs

23 June 2024

39

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

23 June 2024

Tumor suppressor genes

42

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Human gene therapy comes of age.

23 June 2024

45

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

23 June 2024

46

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy

23 June 2024

50

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo

23 June 2024

51

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

23 June 2024

52

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system

23 June 2024

54

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis

23 June 2024

57

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Mode of Action of 5-Fluorocytosine and Mechanisms of Resistance

23 June 2024

58

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Karnofsky Memorial Lecture. The immunotherapy and gene therapy of cancer

23 June 2024

61

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

23 June 2024

62

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

23 June 2024

63

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction

23 June 2024

64

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

c-abl function in normal and chronic myelogenous leukemia hematopoiesis: in vitro studies with antisense oligomers

23 June 2024

66

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Tumor suppressor genes: the puzzle and the promise

23 June 2024

67

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides

23 June 2024

68

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Gene delivery to glioma cells in rat brain by grafting of a retrovirus packaging cell line

23 June 2024

69

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1

23 June 2024

70

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Transposition of cloned P elements into Drosophila germ line chromosomes.

23 June 2024

71

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors

23 June 2024

72

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin-2

23 June 2024

74

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

An experimental model of retrovirus gene therapy for malignant brain tumors

23 June 2024

75

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

The tumor-cytokine transplantation assay and the antitumor activity of interleukin-4

23 June 2024

76

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Murine interleukin-4 displays potent anti-tumor activity in vivo

23 June 2024

77

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

Current approaches to the adoptive immunotherapy of cancer

23 June 2024

80

1 reference

https://api.crossref.org/works/10.1016/0163-7258(94)00081-D

23 June 2024

Identifiers

1 reference

20 September 2017

1 reference